TY  - GEN
AU  - Kosmidis,Paris A
AU  - Syrigos,Konstantinos
AU  - Kalofonos,Haralampos P
AU  - Dimopoulos,Meletios-Athanasios
AU  - Skarlos,Dimosthenis
AU  - Pavlidis,Nicolas
AU  - Boukovinas,Ioannis
AU  - Bafaloukos,Dimitrios
AU  - Pectasides,Dimitrios
AU  - Bacoyiannis,Charalampos
AU  - Fountzilas,George
TI  - Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2
SN  - 1791-7530
PY  - 2012///0224
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bone Neoplasms
KW  - Brain Neoplasms
KW  - Carcinoma, Large Cell
KW  - diagnosis
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Carcinoma, Squamous Cell
KW  - Disease Progression
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Liver Neoplasms
KW  - Lung Neoplasms
KW  - Lymphatic Metastasis
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm Staging
KW  - Paclitaxel
KW  - administration & dosage
KW  - Small Cell Lung Carcinoma
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Vinblastine
KW  - Vinorelbine
N1  - Publication Type: Journal Article; Randomized Controlled Trial
ER  -